Xiang J - Search Results

1

Human dendritic cells engineered to express alpha tumor necrosis factor maintain cellular maturation and T-cell stimulation capacity.

Ye Z, Chen Z, Sami A, El-Gayed A, Xiang J. Ye Z, et al. Among authors: xiang j. Cancer Biother Radiopharm. 2006 Dec;21(6):613-22. doi: 10.1089/cbr.2006.21.613. Cancer Biother Radiopharm. 2006. PMID: 17257077

2

Analysis of the gene expression profiles of immature versus mature bone marrow-derived dendritic cells using DNA arrays.

Chen Z, Gordon JR, Zhang X, Xiang J. Chen Z, et al. Among authors: xiang j. Biochem Biophys Res Commun. 2002 Jan 11;290(1):66-72. doi: 10.1006/bbrc.2001.6147. Biochem Biophys Res Commun. 2002. PMID: 11779134

3

Adenovirus-mediated CD40 ligand gene-engineered dendritic cells elicit enhanced CD8(+) cytotoxic T-cell activation and antitumor immunity.

Liu Y, Zhang X, Zhang W, Chen Z, Chan T, Ali K, Jia Z, Xiang J. Liu Y, et al. Among authors: xiang j. Cancer Gene Ther. 2002 Feb;9(2):202-8. doi: 10.1038/sj.cgt.7700429. Cancer Gene Ther. 2002. PMID: 11857039

4

Antitumor immune responses derived from transgenic expression of CD40 ligand in myeloma cells.

Liu Y, Qureshi M, Xiang J. Liu Y, et al. Among authors: xiang j. Cancer Biother Radiopharm. 2002 Feb;17(1):11-8. doi: 10.1089/10849780252824028. Cancer Biother Radiopharm. 2002. PMID: 11915168

5

Synergistic enhancement of antitumor immunity with adoptively transferred tumor-specific CD4+ and CD8+ T cells and intratumoral lymphotactin transgene expression.

Huang H, Li F, Gordon JR, Xiang J. Huang H, et al. Among authors: xiang j. Cancer Res. 2002 Apr 1;62(7):2043-51. Cancer Res. 2002. PMID: 11929823

6

Enhanced HER-2/neu-specific antitumor immunity by cotransduction of mouse dendritic cells with two genes encoding HER-2/neu and alpha tumor necrosis factor.

Chen Z, Huang H, Chang T, Carlsen S, Saxena A, Marr R, Xing Z, Xiang J. Chen Z, et al. Among authors: xiang j. Cancer Gene Ther. 2002 Sep;9(9):778-86. doi: 10.1038/sj.cgt.7700498. Cancer Gene Ther. 2002. PMID: 12189528

7

Engineered fusion hybrid vaccine of IL-4 gene-modified myeloma and relative mature dendritic cells enhances antitumor immunity.

Liu Y, Zhang W, Chan T, Saxena A, Xiang J. Liu Y, et al. Among authors: xiang j. Leuk Res. 2002 Aug;26(8):757-63. doi: 10.1016/s0145-2126(02)00002-4. Leuk Res. 2002. PMID: 12191571

8

DNA microarray analysis of the gene expression profiles of naïve versus activated tumor-specific T cells.

Zhang X, Chen Z, Huang H, Gordon JR, Xiang J. Zhang X, et al. Among authors: xiang j. Life Sci. 2002 Nov 8;71(25):3005-17. doi: 10.1016/s0024-3205(02)02164-1. Life Sci. 2002. PMID: 12384184

9

Genetic engineering of dendritic cells by adenovirus-mediated TNF-alpha gene transfer.

Xiang J, Wu J. Xiang J, et al. Methods Mol Biol. 2003;215:213-25. doi: 10.1385/1-59259-345-3:213. Methods Mol Biol. 2003. PMID: 12512301 No abstract available.

10

Advances in dendritic cell-based vaccine of cancer.

Zhang X, Gordon JR, Xiang J. Zhang X, et al. Among authors: xiang j. Cancer Biother Radiopharm. 2002 Dec;17(6):601-19. doi: 10.1089/108497802320970217. Cancer Biother Radiopharm. 2002. PMID: 12537664 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,314 results

Search Page

Filters